Compare COO & LI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | LI |
|---|---|---|
| Founded | 1980 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 17.5B |
| IPO Year | N/A | 2020 |
| Metric | COO | LI |
|---|---|---|
| Price | $83.71 | $16.98 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 8 |
| Target Price | ★ $88.55 | $20.91 |
| AVG Volume (30 Days) | 2.4M | ★ 4.2M |
| Earning Date | 12-04-2025 | 11-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.87 | 0.62 |
| Revenue | $4,092,400,000.00 | ★ $17,952,966,790.00 |
| Revenue This Year | $6.56 | N/A |
| Revenue Next Year | $5.32 | $26.33 |
| P/E Ratio | $45.09 | ★ $27.36 |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $61.78 | $16.11 |
| 52 Week High | $100.24 | $33.12 |
| Indicator | COO | LI |
|---|---|---|
| Relative Strength Index (RSI) | 63.17 | 42.77 |
| Support Level | $80.23 | $16.82 |
| Resistance Level | $83.64 | $17.74 |
| Average True Range (ATR) | 1.38 | 0.42 |
| MACD | -0.21 | 0.15 |
| Stochastic Oscillator | 71.73 | 53.37 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 500,000 NEVs in 2024, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.